| Product Code: ETC11393283 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius Antihypertensive Drugs Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius Antihypertensive Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius Antihypertensive Drugs Market - Industry Life Cycle |
3.4 Mauritius Antihypertensive Drugs Market - Porter's Five Forces |
3.5 Mauritius Antihypertensive Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Mauritius Antihypertensive Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Mauritius Antihypertensive Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mauritius Antihypertensive Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hypertension in Mauritius |
4.2.2 Rising geriatric population in Mauritius |
4.2.3 Growing awareness about the importance of managing hypertension |
4.2.4 Government initiatives to promote healthcare access and affordability |
4.3 Market Restraints |
4.3.1 High cost of antihypertensive drugs |
4.3.2 Limited healthcare infrastructure in remote areas of Mauritius |
4.3.3 Side effects associated with some antihypertensive medications |
4.3.4 Lack of adherence to treatment regimens among patients |
5 Mauritius Antihypertensive Drugs Market Trends |
6 Mauritius Antihypertensive Drugs Market, By Types |
6.1 Mauritius Antihypertensive Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Mauritius Antihypertensive Drugs Market Revenues & Volume, By Drug Class, 2021 - 2031F |
6.1.3 Mauritius Antihypertensive Drugs Market Revenues & Volume, By Beta Blockers, 2021 - 2031F |
6.1.4 Mauritius Antihypertensive Drugs Market Revenues & Volume, By ACE Inhibitors, 2021 - 2031F |
6.1.5 Mauritius Antihypertensive Drugs Market Revenues & Volume, By Diuretics, 2021 - 2031F |
6.1.6 Mauritius Antihypertensive Drugs Market Revenues & Volume, By Calcium Channel Blockers, 2021 - 2031F |
6.2 Mauritius Antihypertensive Drugs Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Mauritius Antihypertensive Drugs Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Mauritius Antihypertensive Drugs Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3 Mauritius Antihypertensive Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Mauritius Antihypertensive Drugs Market Revenues & Volume, By Retail, 2021 - 2031F |
6.3.3 Mauritius Antihypertensive Drugs Market Revenues & Volume, By Hospital, 2021 - 2031F |
6.3.4 Mauritius Antihypertensive Drugs Market Revenues & Volume, By Online, 2021 - 2031F |
6.3.5 Mauritius Antihypertensive Drugs Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
7 Mauritius Antihypertensive Drugs Market Import-Export Trade Statistics |
7.1 Mauritius Antihypertensive Drugs Market Export to Major Countries |
7.2 Mauritius Antihypertensive Drugs Market Imports from Major Countries |
8 Mauritius Antihypertensive Drugs Market Key Performance Indicators |
8.1 Average blood pressure control rate among hypertensive patients in Mauritius |
8.2 Number of healthcare facilities providing hypertension management services |
8.3 Percentage of hypertensive patients receiving regular screenings and follow-up care |
8.4 Adoption rate of newer, more effective antihypertensive medications |
8.5 Patient satisfaction with hypertension treatment and overall healthcare experience |
9 Mauritius Antihypertensive Drugs Market - Opportunity Assessment |
9.1 Mauritius Antihypertensive Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Mauritius Antihypertensive Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Mauritius Antihypertensive Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mauritius Antihypertensive Drugs Market - Competitive Landscape |
10.1 Mauritius Antihypertensive Drugs Market Revenue Share, By Companies, 2024 |
10.2 Mauritius Antihypertensive Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here